Bicycle Therapeutics Ltd (BCYC)

Bicycle Therapeutics Ltd (BCYC) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $245M; returns 1 day -2.5%, 1 week +2.6%, 1 year -54.5%.

Bicycle Therapeutics plc (BCYC) is a clinical-stage biopharmaceutical company focused on pioneering a novel class of therapeutics called 'Bicycles®' (bicyclic peptides) for diseases currently underserved by existing treatments, primarily within oncology.

Groups BCYC belongs to

• United Kingdom Companies
• Biotechnology
• Clinical Stage Biopharma
• Biopharmaceutical
• Oncology
• Clinical Stage Biotech
• Clinical Stage
• Antibody-Drug Conjugates
• Precision Medicine
• Drug Discovery

BCYC financial model: income statement, cash flow and balance sheet